Overview

A Study to Compare the Efficacy and Safety of Tacrolimus Capsules and Cyclophosphamide Injection in Treatment of Lupus Nephritis

Status:
Completed

Trial end date:
2018-09-10

Target enrollment:

Participant gender:

Summary

The objective of this study is to evaluate the efficacy and safety of Tacrolimus capsules for induction remission in patients with lupus nephritis, and compare the efficacy and safety with Cyclophosphamide injections.

Phase:

Phase 3

Details

Lead Sponsor:

Astellas Pharma China, Inc.

Treatments:

Cyclophosphamide
Prednisone
Tacrolimus